Muscle Building Formula - MyoBlox Contra Muscle Builder
If you're looking for an extreme Muscle builder, look no further. MyoBlox Contra Muscle Builder was formulated just for you. Contra was made to help provide Gym Junkies like you with lean gains & insanely huge pumps. Contra's formula contains Anti-Cortisol & Anti-Estrogen properties. Try it out today. Introducing MyoBlox Contra Muscle Builder!!
MyoBlox Contra Muscle Builder Benefits
- Provides Extreme Gains
- Helps Support Rock Hard Muscles
- Supports Extreme Shirt-Splitting Pumps
- Contains Anti-Cortisol & Anti-Estrogen Properties
- Helps To Give The Coveted "Hard" Look
How Do I Take MyoBlox Contra Muscle Builder?
Start by taking one dose (1 Capsule) in the morning with your first meal. Wait approximately 8-12 hours, consume second dose (1 Capsule) with meal. Due to potency do not use this product longer than 8 weeks followed by a subsequent 4 week break. Do not exceed 2 capsules in any 24 hour period.
MyoBlox Contra Muscle Builder Ingredients
Serving Size: 2 Capsules
Servings Per Container: 28
Contra (2 Capsules) 1150mg
Anti-Cortisol Matrix 600mg: KSM-66 Ashwagandha Root Extract (Standardized To >5% Withanolides)
Pro-Physique Matrix 540mg: 3,3'-Diindolymethane, Androsta-3,5, Diene-7,17-Dione, N-Cuomaroyldopamine, BLOX Micro Peptide Technology (Yielding Natural Occurring Fibroblast Growth Factors, Folistatin)
Absorption Matrix 10mg: Piperine Alkaloids (98%)
Other Ingredients: Silicon Dioxide, Rice Flour, Gelatin.
MyoBlox Contra Muscle Builder Side Effects & Warnings
Do not consume more than 2 capsules in a 24 hour period. Store in a cool dry place.
Pratte MA, Nanavati KB, Young V, Morley CP. An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). J Altern Complement Med. 2014;20(12):901–908. doi:10.1089/acm.2014.0177
Kurapati KR, Atluri VS, Samikkannu T, Nair MP. Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). PLoS One. 2013;8(10):e77624. Published 2013 Oct 16. doi:10.1371/journal.pone.0077624